Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Hydroxyprogesterone
Drug ID BADD_D01106
Description Not Available
Indications and Usage Not Available
Marketing Status experimental
ATC Code G03DA03
DrugBank ID DB14570
KEGG ID D08052
MeSH ID D000077713
PubChem ID 6238
TTD Drug ID D00AEQ
NDC Product Code 73309-243
UNII 21807M87J2
Synonyms 17 alpha-Hydroxyprogesterone Caproate | 17 alpha Hydroxyprogesterone Caproate | 17-alpha-Hydroxy-Progesterone Caproate | 17 alpha Hydroxy Progesterone Caproate | Caproate, 17-alpha-Hydroxy-Progesterone | Oxyprogesterone Caproate | Hydroxyprogesterone Caproate | Hydroxyprogesterone Hexanoate | 17 alpha-Oxyprogesterone Capronate | 17 alpha Oxyprogesterone Capronate | 17-Hydroxyprogesterone Capronate | 17 Hydroxyprogesterone Capronate | Prolutin Depot | Proluton Depot | Neolutin | Makena | Delalutin
Chemical Information
Molecular Formula C21H30O3
CAS Registry Number 68-96-2
SMILES CC(=O)C1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abortion spontaneous18.01.04.001---
Asthenia08.01.01.001---
Body temperature increased13.15.01.001---
Cervical incompetence18.02.02.009; 21.06.01.008---
Chest discomfort02.02.02.009; 08.01.08.019; 22.12.02.002---
Chest pain02.02.02.011; 08.01.08.002; 22.12.02.003---
Dermatitis23.03.04.002---
Diarrhoea07.02.01.001--
Dizziness02.11.04.006; 17.02.05.003; 24.06.02.007--
Dyspnoea02.11.05.003; 22.02.01.004--
Erythema23.03.06.001---
Fatigue08.01.01.002--
Feeling hot08.01.09.009---
Flushing08.01.03.025; 23.06.05.003; 24.03.01.002--
Gestational diabetes05.06.01.008; 14.06.01.008; 18.02.04.001---
Headache17.14.01.001--
Hypersensitivity10.01.03.003--
Infection11.01.08.002---
Injection site pain08.02.03.010; 12.07.03.011---
Injection site pruritus08.02.03.013; 12.07.03.014; 23.03.12.007---
Injection site reaction08.02.03.014; 12.07.03.015--
Menopausal symptoms21.02.02.002---
Nausea07.01.07.001--
Nervous system disorder17.02.10.001---
Oligohydramnios18.05.01.001---
Pre-eclampsia18.02.03.002; 20.01.08.002; 24.08.07.002---
Pregnancy18.08.02.004---
Premature baby18.04.02.001---
Premature delivery18.07.01.006--
Premature labour18.07.01.002---
The 1th Page    1 2    Next   Last    Total 2 Pages